Luna Krstic

Ms. Luna Krstic

University of Valladolid
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Luna KrsticLuna Krstic
Luna Krstic
MGMaría J. González-García
María J. González-García
YDYolanda Diebold
Yolanda Diebold
Nature has become one of the main sources of exploration for researchers that search for new potential molecules to be used in therapy. Polyphenols are emerging as a class of compounds that have attracted the attention of pharmaceutical and biomedical scientists. Thanks to their structural peculiarities, polyphenolic compounds are characterized as good scavengers of free radical species. This, among other medicinal effects, permits them to interfere with different molecular pathways that are involved in the inflammatory process. Unfortunately, many compounds of this class possess low solubility in aqueous solvents and low stability. Ocular pathologies are spread worldwide. It is estimated that every individual at least once in their lifetime experiences some kind of eye disorder. Oxidative stress or inflammatory processes are the basic etiological mechanisms of many ocular pathologies. A variety of polyphenolic compounds have been proved to be efficient in suppressing some of the indicators of these pathologies in in vitro and in vivo models. Further application of polyphenolic compounds in ocular therapy lacks an adequate formulation approach. Therefore, more emphasis should be put in advanced delivery strategies that will overcome the limits of the delivery site as well as the ones related to the polyphenols in use. This review analyzes different drug delivery strategies that are employed for the formulation of polyphenolic compounds when used to treat ocular pathologies related to oxidative stress and inflammation.

25 January 2022 in Foods
Verified
Journal Article
Open access
PDF file
Maha AbdallahMaha Abdallah
Maha Abdallah
ILInês Leonardo
Inês Leonardo
Luna KrsticLuna Krstic
Luna Krstic
Amalia Enríquez-de-SalamancaAmalia Enríquez-de-Salamanca
Amalia Enríquez-de-Salamanca
YDYolanda Diebold
Yolanda Diebold
NFNaiara Fernández
Naiara Fernández
A green technique was developed to extract hyaluronic acid (HA) from tuna vitreous humor (TVH) for its potential application in managing dry eye disease. Deep eutectic solvents (DES) were used to extract HA and were synthesized using natural compounds (lactic acid, fructose, and urea). The DES, the soluble fraction of TVH in DES (SF), and the precipitated extracts (PE) were evaluated for their potential use in dry eye disease treatment. In vitro experiments on human corneal epithelial cell lines and the effect on dry eye-associated microorganisms were performed. The influence of the samples on the HCE viability, their intracellular reactive oxygen species (ROS) scavenging capacity, inflammatory response, and antimicrobial properties were studied. According to the results, all samples displayed an antioxidant effect, which was significantly higher for PE in comparison to SF. Most of the tested samples did not induce an inflammatory response in cells, which confirmed the safety in ophthalmic formulations. In addition, the DES and SF proved to be efficient against the studied bacterial strains, while PE did not show an antimicrobial effect. Hence, both DES and SF at defined concentrations could be used as potential compounds in dry eye disease management.

7 May 2025 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Luna KrsticLuna Krstic
Luna Krstic
RVReinaldo Vallejo
Reinaldo Vallejo
SRS. Rodriguez-Rojo
S. Rodriguez-Rojo
MGMaría J. González-García
María J. González-García
FAF. Javier Arias
F. Javier Arias
YDYolanda Diebold
Yolanda Diebold